Patents Examined by Amy Lam
  • Patent number: 7138245
    Abstract: Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: November 21, 2006
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Steven R. Binder, Jodi L. Goodrich, Zara Safarian